Richard Harris

Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.

Harris has traveled to all seven continents for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest, the foot of Mt. Kilimanjaro (for a story about tuberculosis), and Japan to cover the nuclear aftermath of the 2011 tsunami.
In 2010, Harris' reporting revealed that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. That revelation led the federal government to make a more realistic assessment of the extent of the spill.

Harris covered climate change for decades. He reported from the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, and including Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR's award-winning 2007-2008 "Climate Connections" series.

Over the course of his career, Harris has been the recipient of many prestigious awards. Those include the American Geophysical Union's 2013 Presidential Citation for Science and Society. He shared the 2009 National Academy of Sciences Communication Award and was a finalist again in 2011. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry. Since 1988, the American Association for the Advancement of Science has honored Harris three times with its science journalism award.

Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues related to the nuclear weapons lab in Livermore. He started his career as an AAAS Mass Media Science Fellow at the now-defunct Washington (DC) Star.

Harris is co-founder of the Washington, D.C., Area Science Writers Association, and is past president of the National Association of Science Writers. He serves on the board of the Council for the Advancement of Science Writing.

A California native, Harris returned to the University of California-Santa Cruz in 2012, to give a commencement address at Crown College, where he had given a valedictory address at his own graduation. He earned a bachelor's degree at the school in biology, with highest honors.

Pages

Goats and Soda
4:06 am
Tue September 30, 2014

Tests Of New Ebola Drugs Could Take Place As Early As November

Some potential new Ebola drugs will be tested at treatment centers like this one run by Doctors Without Borders near Monrovia.
John Moore Getty Images

Originally published on Tue September 30, 2014 12:46 pm

Health officials are gearing up to test drugs and vaccines against Ebola in West Africa, and they hope to start within two months. That's an ambitious timeline for a process that often takes years. The challenge is to move forward as quickly as possible while minimizing the risks that come with unproven drugs and vaccines.

Right now there are no proven medications. But researchers have been working methodically for years on vaccines that could protect people from the Ebola virus — and drugs that could treat the sick.

Read more
Shots - Health News
10:57 am
Wed September 24, 2014

After The NIH Funding 'Euphoria' Comes The 'Hangover'

Originally published on Fri September 26, 2014 10:02 am

When Richard Larson co-wrote a scientific paper about the perils of up-and-down funding for the National Institutes of Health, he noted that the research cycled between states of "euphoria," and a "hangover" far greater than you'd expect.

Read more
Shots - Health News
3:11 am
Wed September 17, 2014

Top Scientists Suggest A Few Fixes For Medical Funding Crisis

Dr. Harold Varmus, a Nobel Prize winner, cancer biologist and director of the National Cancer Institute.
Manuel Balce Ceneta AP

Originally published on Thu September 18, 2014 7:02 am

Many U.S. scientists had hoped to ride out the steady decline in federal funding for biomedical research, but it's continuing on a downward trend with no end in sight. So leaders of the science establishment are now trying to figure out how to fix this broken system.

It's a familiar problem. Biomedical science has a long history of funding ups and downs, and, in the past, the system has always righted itself with the passage of time and plumper budgets.

Read more
Shots - Health News
3:19 pm
Tue September 16, 2014

Breast Cancer Patients Seek More Control Over Research Agenda

Coalitions of patient advocates now help steer research funding toward particular projects.
Lilli Carré for NPR

Originally published on Tue September 23, 2014 10:23 am

The federal government has poured more than $3 billion into breast cancer research over the past couple of decades, but the results have been disappointing. The disease remains a stubborn killer of women.

So the National Breast Cancer Coalition is trying something bold: The advocacy group has decided that it's not simply going to lobby for more research dollars. Instead, its leaders are sitting down at the table with scientists studying the disease and telling them how they'd like that money to be spent.

Read more
The Salt
10:40 am
Tue September 16, 2014

A Scientist's Journey From Beer To Microbiology To Bourbon-Making

Ian Glomski outside his home in Charlottesville, Va., where hops grow in his garden. He quit an academic career in microbiology to start a liquor distillery.
Richard Harris NPR

Originally published on Tue September 16, 2014 1:18 pm

If you have been following the various posts about beer on The Salt, you may have noticed a pattern: Many of the folks making beer have a scientific background. There's good reason for that. People don't make beer. Yeast does. Well, OK — it's a partnership.

And sometimes, it's a two-way street between the brewery and the lab.

Read more
Shots - Health News
2:38 am
Tue September 16, 2014

Too Few University Jobs For America's Young Scientists

Victoria Ruiz (left), a postdoctoral fellow in immunology, works with Brianna Delgado, a high school student that she mentors, at the Blaser Lab, inside NYU's Langone Medical Center in New York, NY.
Ramsay de Give for NPR

Originally published on Tue September 30, 2014 7:21 pm

Imagine a job where about half of all the work is being done by people who are in training. That's, in fact, what happens in the world of biological and medical research.

In the United States, more than 40,000 temporary employees known as postdoctoral research fellows are doing science at a bargain price. And most postdocs are being trained for jobs that don't actually exist.

Read more
Shots - Health News
3:52 am
Mon September 15, 2014

Patients Vulnerable When Cash-Strapped Scientists Cut Corners

Tom Murphy, 56, in his home in Gainesville, Va., was diagnosed with ALS four years ago. An experimental drug seems to have slowed the progression of his disease, he says, though most ALS patients aren't as lucky.
T.J. Kirkpatrick for NPR

Originally published on Tue September 16, 2014 8:09 am

There's a funding crunch for biomedical research in the United States — and it's not just causing pain for scientists and universities. It's also creating incentives for researchers to cut corners — and that's affecting people who are seriously ill.

Read more
Research News
4:10 am
Wed September 10, 2014

Built In Better Times, University Labs Now Lack Research Funding

Originally published on Wed September 10, 2014 7:01 am

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Shots - Health News
4:13 pm
Tue September 9, 2014

When Scientists Give Up

Randen Patterson left a research career in physiology at U.C. Davis when funding got too tight. He now owns a grocery store in Guinda, Calif.
Max Whittaker/Prime for NPR

Originally published on Wed September 10, 2014 2:29 pm

Ian Glomski thought he was going to make a difference in the fight to protect people from deadly anthrax germs. He had done everything right — attended one top university, landed an assistant professorship at another.

But Glomski ran head-on into an unpleasant reality: These days, the scramble for money to conduct research has become stultifying.

So, he's giving up on science.

Read more
Shots - Health News
2:29 am
Tue September 9, 2014

U.S. Science Suffering From Booms And Busts In Funding

Leif Parsons for NPR

Originally published on Tue September 16, 2014 5:43 pm

Ten years ago, Robert Waterland got an associate professorship at Baylor College of Medicine and set off to study one of the nation's most pressing health problems: obesity. In particular, he's been trying to figure out the biology behind why children born to obese women are more likely to develop the condition themselves.

Waterland got sustaining funding from the National Institutes of Health and used it to get the project going.

Read more
Africa
3:10 pm
Thu August 21, 2014

Why Ebola Is Making It Harder To Provide Good Health Care

Protective equipment is in short supply. Here, a Liberian burial team carefully disinfects its gloves before disposing of them.
John Moore Getty Images

Originally published on Thu August 21, 2014 10:28 pm

The Ebola virus has killed more than 1,300 people in West Africa, but the indirect deaths caused by this epidemic are likely to be far worse. Right now, it's the rainy season. And that means it's high season for malaria.

"Probably 85 percent of the fevers right now are malaria," says Laura Miller, health coordinator in Sierra Leone for the International Rescue Committee. "But more of those cases will go untreated than usual."

Read more
Goats and Soda
4:24 pm
Fri August 15, 2014

Even With $100 Million, WHO Says It Will Take Months To Control Ebola

A health worker cleans his hands with chlorinated water before entering an Ebola screening tent at the Kenema Government Hospital in Sierra Leone. More than 300 Sierra Leoneans have died of the disease.
Michael Duff AP

Originally published on Fri August 15, 2014 8:50 pm

When public health officials warn that it's likely to take many months to bring the Ebola outbreak in West Africa under control, it's not because they're facing a single huge challenge.

"If there was just one solid, large chunk we could slice out, we would," says WHO spokeswoman Nyka Alexander, at the agency's regional coordination center in Conakry, Guinea. "But it's so many little things that add up to the outbreak."

Read more
Global Health
4:27 am
Tue August 12, 2014

Why Is There No Drug To Treat Ebola?

Originally published on Tue August 12, 2014 6:42 am

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

STEVE INSKEEP, HOST:

Read more
Shots - Health News
11:37 am
Fri August 8, 2014

Investors Pump Prospects Of Unproven Ebola Treatments

Tobacco plants grown at an Owensboro, Ky., biotechnology firm were used to help produce an experimental serum used to treat two Americans infected with Ebola.
AP

Originally published on Fri August 8, 2014 12:24 pm

Interest in drugs that might be used to treat Ebola virus has hit a fever pitch, but the buzz isn't simply about fear of Ebola, or about saving lives in poor nations of West Africa. It's also about money.

Read more
Shots - Health News
6:03 am
Sat August 2, 2014

Why Treating Ebola With An Experimental Serum Might Help

In 1995, amid an Ebola outbreak, Zairian Red Cross personnel picked up sick people and bodies left on the streets of Kikwit, 250 miles from the capital Kinshasa.
Jean-Marc Bouju AP

Originally published on Mon August 25, 2014 10:23 am

Last week we learned that two Americans working in Liberia for a medical charity, Samaritan's Purse, were among those who had contracted Ebola. When their symptoms took a turn for the worse, the organization announced that the two were going to get experimental treatments. One was going to get a blood transfusion from a 14-year-old boy who recovered from the disease, the organization said; the other was to get an "experimental serum." What's that?

Read more

Pages